Salvia divinorum
1Provenance card
the boundary, as counts
Sources
3425 with DOI
10 strong · 18 moderate · 6 weak
Compilations
12026-05-14T09:20:50.851Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09 · 1 other run
Decisions
21last ruled 2026-06-04
0 awaiting a ruling
Issued documents
42026-10-19T20:33:58.018Z
notice · info card · emergency
Searches
202 with no results
queries and counts on the build
Claims checked
8134 supported
34 supported · 47 not
Correspondence
0received
consent field ships in Phase 4
Edges
247
derivations recorded for this entity
Complete over 34 sources, 1 compilation, and 21 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/salvia-divinorum/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued info_card
- 2026-09-27runbrief run
- 2026-09-27revisionr2.a1
- 2026-09-07srcSalvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug
- 2026-09-07srcSalvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors.
- 2026-09-07srcLack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial.
- 2026-09-07srcAcute and post-acute behavioral and psychological effects of salvinorin A in humans
- 2026-09-07srcDose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects.
- 2026-09-07srcEvolution and origins of the Mazatec hallucinogenic sage, Salvia divinorum (Lamiaceae): a molecular phylogenetic approach
- 2026-09-07srcCorrelates of Salvia divinorum use in a national sample: findings from the 2009 National Survey on Drug Use and Health
- 2026-09-07srcDose-related behavioral, subjective, endocrine, and psychophysiological effects of the kappa opioid agonist Salvinorin A in humans.
- 2026-09-07srcHuman psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum
- 2026-09-07srcEvaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen
- 2026-09-07srcFrom local to global-fifty years of research on Salvia divinorum.
- 2026-09-07srcRapid Detection and Quantification of Hallucinogenic Salvinorin A in Commercial Salvia divinorum Products by DART-HRMS
- 2026-09-07srcThe translational potential of salvinorin A: systematic review and meta-analysis of preclinical studies.
- 2026-09-07srcChemical syntheses of the salvinorin chemotype of KOR agonist
- 2026-09-07srcSalvia divinorum and Salvinorin A: An Update on Pharmacology and Analytical Methodology
- 2026-09-07srcThe Association of Salvia divinorum and Psychotic Disorders: A Review of the Literature and Case Series.
- 2026-09-07srcQuite a Profoundly Strange Experience: An Analysis of the Experiences of Salvia divinorum Users.
- 2026-09-07srcNaltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.
- 2026-09-07srcSalvia divinorum: An overview of the usage, misuse, and addiction processes
- 2026-09-07srcLearning and memory impairment induced by salvinorin A, the principal ingredient of Salvia divinorum, in wistar rats
- 2026-09-07srcCase report: the psychotic-mystical effects related to an unaware use of Salvia divinorum
- 2026-09-07srcSalvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
- 2026-09-07srcOpioid Receptors in Psychedelia: Indirect Serotonergic Modulation of Direct KOR Activation by Salvinorin A.
- 2026-09-07srcSalvinorin A and Salvia divinorum: Toxicology, Pharmacological Profile, and Therapeutic Potential
- 2026-09-07srcPharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects
- 2026-09-07srcSalvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
- 2026-09-07srcSalvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
- 2026-09-07srcDepressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats
- 2026-09-07srcThe detection and quantitative analysis of the psychoactive component of Salvia divinorum, salvinorin A, in human biological fluids using liquid chromatography-mass spectrometry
- 2026-09-07srcSalvia divinorum: a psychopharmacological riddle and a mind-body prospect.
- 2026-09-07srcSalvia divinorum drug profile
- 2026-09-07srcLegal status of Salvia divinorum in the United States - Wikipedia
- 2026-09-07srcSalvia divinorum - Plants of the World Online (POWO), Kew Science
- 2026-09-07srcLegal status of Salvia divinorum - international overview
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-06-04proposal15 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-05-14revisionRevision 2
- 2026-05-14absenceSearched PubMed for "Salvia divinorum legal status scheduling controlled substance" — no results
- 2026-05-14absenceSearched PubMed for "Salvia divinorum ethnobotany history traditional use Mazatec" — no results
- 2026-05-14genGeneration — pipeline-v5 · with 1 morepipeline-v5
- 2026-05-14rungeneration run
- 2026-03-17importImported from Curiosity v1
- 2026-03-17publicationPublication — backfill
- 2026-03-17revisionRevision 1
The same entries, as forms: six forms.